LGND - Ligand Quarterly EPS earnings growth

Official company branding of Ligand Pharmaceuticals (LGND)

The history of quarterly earnings per share changes confirms the stability of license and patent management for Ligand Pharmaceuticals (LGND). The current level is -125.60. Growth is based on a lack of bureaucracy and a strategic focus on intellect. High revenue per specialist and premium payouts ensure the loyalty of an elite workforce. A compact staff of biochemists with minimal turnover guarantees the predictability of cash flows.

Ligand (LGND) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/18/2026

Summary analytical data breakdowns for Ligand Pharmaceuticals (LGND)

- share price and expert price forecast:
Fundamental company analysis:Ligand Pharmaceuticals Incorporated - LGND
Flagship merchandise of Ligand Corp

Ligand Pharmaceuticals (LGND) maintains a strong position due to its unique patent portfolio. The quarterly EPS growth trend measures the rate of increase in net profit per share, reflecting the efficiency of converting revenue into income. Investors utilize this balance to assess the business's resilience to external shocks. Geopolitical barriers in technology licensing directly impact the level of quarterly EPS growth. Sharp peaks in this indicator may foreshadow an imminent price correction.

Competitor analysis

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ALVO (Alvotech S.A.)|Liquidia Technologies - Year-over-year earnings per share growth for the last twelve months|Galapagos Corp - Quarterly EPS earnings growth|ANIP (ANI Pharmaceuticals) - Year-over-year earnings per share growth for the last 12 months|MannKind Corp. (MNKD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Quarterly EPS earnings growth|SPRY: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TBPH|Year-over-year net earnings per share change for the last twelve months Aquestive Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Year-over-year earnings per share growth for the last 12 months|TNXP - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months SXT Pharmaceuticals SXTC|EPRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bioharvest.com (BHST)|Year-over-year net earnings per share growth for the last 12 months EXOZ|ORMP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ABVC (ABVC BioPharma, Inc)|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FibroGen Corp (FGEN) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Year-over-year earnings per share growth for the last twelve months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)